Showing results (21-30 of 236) with videos related to
Sort By:
Pageof 24
Psychopharmacology Communications|January 11, 1975
Serotonin (5HT) systems in psychotic statesM B BowersBiological Psychiatry|June 1, 1978
CSF acid monoamine metabolites in psychotic syndromes: what might they signify?M B BowersThe American Journal of Psychiatry|February 11, 1991
Characteristics of psychotic inpatients with high or low HVA levels at admissionM B BowersThe Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's diseaseM B BowersArchives of General Psychiatry|July 1, 1977
Psychoses precipitated by psychotomimetic drugs. A follow-up studyM B BowersJournal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|December 6, 2002
Mothers' experiences of labor support: exploration of qualitative researchBeverly B BowersClinical Pharmacology and Therapeutics|January 11, 1975
Thioridazine: central dopamine turnover and clinical effects of antipsychotic drugsM B BowersThe American Journal of Psychiatry|February 1, 1984
Family history and CSF homovanillic acid pattern during neuroleptic treatmentM B BowersDiabetologia|March 1, 1997
Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic ratsN E Cameron, M A Cotter, M Basso, et al.Journal of Diabetes and Its Complications|January 1, 1996
Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic ratsN E Cameron, M A Cotter, K C Dines, et al.Pageof 24